Annual Total Debt
$428.40 M
+$165.50 M+62.95%
31 December 2023
Summary:
Neurocrine Biosciences annual total debt is currently $428.40 million, with the most recent change of +$165.50 million (+62.95%) on 31 December 2023. During the last 3 years, it has risen by +$16.10 million (+3.90%). NBIX annual total debt is now -13.54% below its all-time high of $495.50 million, reached on 31 December 2019.NBIX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$251.40 M
-$4.80 M-1.87%
30 September 2024
Summary:
Neurocrine Biosciences quarterly total debt is currently $251.40 million, with the most recent change of -$4.80 million (-1.87%) on 30 September 2024. Over the past year, it has dropped by -$22.20 million (-8.11%). NBIX quarterly total debt is now -50.89% below its all-time high of $511.90 million, reached on 31 March 2024.NBIX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.0% | -8.1% |
| 3 y3 years | +3.9% | -42.5% |
| 5 y5 years | +10.3% | -47.4% |
NBIX Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.7% | +63.0% | -50.9% | at low |
| 5 y | 5 years | -13.5% | +63.0% | -50.9% | at low |
| alltime | all time | -13.5% | -50.9% |
Neurocrine Biosciences Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $251.40 M(-1.9%) |
| June 2024 | - | $256.20 M(-50.0%) |
| Mar 2024 | - | $511.90 M(+19.5%) |
| Dec 2023 | $428.40 M(+63.0%) | $428.40 M(+56.6%) |
| Sept 2023 | - | $273.60 M(-1.0%) |
| June 2023 | - | $276.50 M(+6.4%) |
| Mar 2023 | - | $259.90 M(-1.1%) |
| Dec 2022 | $262.90 M(-40.3%) | $262.90 M(-1.1%) |
| Sept 2022 | - | $265.80 M(-1.0%) |
| June 2022 | - | $268.60 M(-44.1%) |
| Mar 2022 | - | $480.20 M(+9.0%) |
| Dec 2021 | $440.40 M(+6.8%) | $440.40 M(+0.8%) |
| Sept 2021 | - | $437.10 M(+0.4%) |
| June 2021 | - | $435.30 M(+1.4%) |
| Mar 2021 | - | $429.50 M(+4.2%) |
| Dec 2020 | $412.30 M(-16.8%) | $412.30 M(-18.8%) |
| Sept 2020 | - | $508.00 M(+0.8%) |
| June 2020 | - | $503.80 M(+0.8%) |
| Mar 2020 | - | $499.70 M(+0.8%) |
| Dec 2019 | $495.50 M(+27.5%) | $495.50 M(+3.6%) |
| Sept 2019 | - | $478.07 M(+2.9%) |
| June 2019 | - | $464.65 M(+0.9%) |
| Mar 2019 | - | $460.58 M(+18.6%) |
| Dec 2018 | $388.50 M(+5.1%) | $388.50 M(+1.3%) |
| Sept 2018 | - | $383.65 M(+1.3%) |
| June 2018 | - | $378.88 M(+1.2%) |
| Mar 2018 | - | $374.21 M(+1.2%) |
| Dec 2017 | $369.62 M(>+9900.0%) | $369.62 M(+1.2%) |
| Sept 2017 | - | $365.11 M(+1.2%) |
| June 2017 | - | $360.68 M(>+9900.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00 | $0.00(-100.0%) |
| Sept 2010 | - | $8.53 M(-10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $9.54 M(-9.4%) |
| Mar 2010 | - | $10.53 M(>+9900.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2009 | - | $17.28 M(-4.9%) |
| June 2009 | - | $18.16 M(-0.3%) |
| Mar 2009 | - | $18.22 M(+18.3%) |
| Dec 2008 | $15.40 M(+936.1%) | $15.40 M(+5478.6%) |
| Sept 2008 | - | $276.00 K(-54.1%) |
| June 2008 | - | $601.00 K(-41.4%) |
| Mar 2008 | - | $1.02 M(-31.0%) |
| Dec 2007 | $1.49 M(-97.2%) | $1.49 M(-97.0%) |
| Sept 2007 | - | $50.13 M(-2.1%) |
| June 2007 | - | $51.20 M(-2.3%) |
| Mar 2007 | - | $52.40 M(-2.3%) |
| Dec 2006 | $53.64 M(-9.7%) | $53.64 M(-2.5%) |
| Sept 2006 | - | $54.99 M(-2.6%) |
| June 2006 | - | $56.45 M(-2.6%) |
| Mar 2006 | - | $57.95 M(-2.4%) |
| Dec 2005 | $59.40 M(-10.2%) | $59.40 M(-2.6%) |
| Sept 2005 | - | $60.99 M(-2.6%) |
| June 2005 | - | $62.63 M(-2.8%) |
| Mar 2005 | - | $64.41 M(-2.6%) |
| Dec 2004 | $66.13 M(+81.5%) | $66.13 M(-3.7%) |
| Sept 2004 | - | $68.70 M(+16.7%) |
| June 2004 | - | $58.88 M(+24.9%) |
| Mar 2004 | - | $47.13 M(+29.4%) |
| Dec 2003 | $36.43 M(+359.1%) | $36.43 M(+61.7%) |
| Sept 2003 | - | $22.53 M(+0.3%) |
| June 2003 | - | $22.47 M(+170.6%) |
| Mar 2003 | - | $8.30 M(+4.6%) |
| Dec 2002 | $7.93 M(+39.5%) | $7.93 M(+18.6%) |
| Sept 2002 | - | $6.69 M(+19.6%) |
| June 2002 | - | $5.59 M(+9.3%) |
| Mar 2002 | - | $5.12 M(-10.1%) |
| Dec 2001 | $5.69 M(+47.0%) | $5.69 M(+52.2%) |
| Sept 2001 | - | $3.74 M(-10.3%) |
| June 2001 | - | $4.16 M(+18.2%) |
| Mar 2001 | - | $3.52 M(-8.9%) |
| Dec 2000 | $3.87 M(+24.8%) | $3.87 M(+26.6%) |
| Sept 2000 | - | $3.06 M(+16.1%) |
| June 2000 | - | $2.63 M(-8.4%) |
| Mar 2000 | - | $2.87 M(-7.3%) |
| Dec 1999 | $3.10 M(+3.3%) | $3.10 M(0.0%) |
| Sept 1999 | - | $3.10 M(+34.8%) |
| June 1999 | - | $2.30 M(-36.1%) |
| Mar 1999 | - | $3.60 M(+20.0%) |
| Dec 1998 | $3.00 M(+87.5%) | $3.00 M(>+9900.0%) |
| Sept 1998 | - | $0.00(0.0%) |
| June 1998 | - | $0.00(0.0%) |
| Mar 1998 | - | $0.00(-100.0%) |
| Dec 1997 | $1.60 M(0.0%) | $1.60 M(>+9900.0%) |
| Sept 1997 | - | $0.00(0.0%) |
| June 1997 | - | $0.00(0.0%) |
| Mar 1997 | - | $0.00(-100.0%) |
| Dec 1996 | $1.60 M | $1.60 M(>+9900.0%) |
| Sept 1996 | - | $0.00(0.0%) |
| June 1996 | - | $0.00(-100.0%) |
| Mar 1996 | - | $2.20 M |
FAQ
- What is Neurocrine Biosciences annual total debt?
- What is the all time high annual total debt for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual total debt year-on-year change?
- What is Neurocrine Biosciences quarterly total debt?
- What is the all time high quarterly total debt for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly total debt year-on-year change?
What is Neurocrine Biosciences annual total debt?
The current annual total debt of NBIX is $428.40 M
What is the all time high annual total debt for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual total debt is $495.50 M
What is Neurocrine Biosciences annual total debt year-on-year change?
Over the past year, NBIX annual total debt has changed by +$165.50 M (+62.95%)
What is Neurocrine Biosciences quarterly total debt?
The current quarterly total debt of NBIX is $251.40 M
What is the all time high quarterly total debt for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly total debt is $511.90 M
What is Neurocrine Biosciences quarterly total debt year-on-year change?
Over the past year, NBIX quarterly total debt has changed by -$22.20 M (-8.11%)